Role of a myocardial depressant factor in the pathogenesis of circulatory shock.
D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000096:biosynthesis / Q000097:blood* / Q000302:isolation & purification / Q000378:metabolism / Q000502:physiology; D001775:Blood Circulation; D002415:Cats; D055598:Chemical Phenomena; D002621:Chemistry; D003864:Depression, Chemical; D004285:Dogs; D004336:Drug Antagonism; D005938:Glucocorticoids / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006470:Hemorrhage / Q000097:blood; D066298:In Vitro Techniques; D007511:Ischemia / Q000097:blood; D008208:Lymphatic System / Q000378:metabolism / Q000601:surgery; D008247:Lysosomes / Q000201:enzymology; D010179:Pancreas / Q000201:enzymology; D010180:Pancreatectomy; D010195:Pancreatitis / Q000097:blood; D010447:Peptide Hydrolases / Q000378:metabolism; D010455:Peptides; D006435:Renal Dialysis; D012771:Shock, Hemorrhagic / Q000097:blood / Q000209:etiology* / Q000401:mortality; D012772:Shock, Septic / Q000097:blood; D013997:Time Factors
D000779:Anesthetics, Local; D000889:Anti-Arrhythmia Agents; D005938:Glucocorticoids; D010455:Peptides; D010447:Peptide Hydrolases